Baylor Genetics
12 articles about Baylor Genetics
-
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024
3/4/2024
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will showcase its latest advancements and research discoveries at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting on March 12-16 in Toronto, Canada.
-
Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares Sequencing Approaches for Undiagnosed Patients at Precision Medicine World Conference 2024
1/23/2024
Christine Eng, M.D. will speak on day one at the Precision Medicine World Conference (PMWC) 2024 in Silicon Valley on January 24th at 1:30 p.m. PT at the Showcase Track S2 stage (Hall C/D).
-
Baylor Genetics Accelerates Growth, Combines Clinical and Scientific Expertise with Commercial Capabilities to Meet Increased Needs of Patients, Providers and Partners
1/3/2024
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, continued to accelerate its market leadership and growth over the last 12 months, expanding its test menu, commercial reach, lab operations, technology, and customer experience initiatives.
-
Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC and ASHG Conferences
10/2/2023
Baylor Genetics announced its scientists and genetic counselors will present 10 research abstracts at three major upcoming conferences, including the National Organization for Rare Disorders Breakthrough Summit, National Society of Genetic Counselors Annual Conference, and the American Society of Human Genetics Annual Meeting.
-
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
9/12/2023
Baylor Genetics announced the availability of a new Neurodevelopmental Disorders Panel for children and other patients affected by a suspected or clinically diagnosed autism spectrum disorder, intellectual disability, and/or developmental delay.
-
Baylor Genetics Announces Epilepsy PanelLatest Panel Analyzes 397 Genes Associated with Several Epilepsy Conditions, Offering an Analysis of Well-studied, Actionable Genes Related to Many Syndromic and Non-Syndromic Epileptic Disorders
7/11/2023
Baylor Genetics announced the availability of an Epilepsy Panel and a STAT Epilepsy Panel - with the latter intended for patients with new onset or change in seizure frequency or character.
-
Baylor Genetics Announces Neuromuscular Disorders Panel
5/22/2023
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing and precision medicine, announced the availability of a Neuromuscular Disorders Panel.
-
FUJIFILM Dyosynth Biotechnologies, Taysha Gene Therapies, Veravas highlight innovation stemming from the Lone Star state. BioSpace takes a deep dive into these and other Texas innovators.
-
Baylor Genetics Launches Combination Test for COVID-19 and Influenza A and B; Multi-Panel Test Seeks to Address Dilemma of "Overlapping symptoms caused by Distinct Diseases."
11/17/2020
With the arrival of flu season, Baylor Genetics, a pioneer of genetic testing and precision medicine, has launched the latest combination test for the novel coronavirus, SARS-CoV-2, and Influenza A and B. "Baylor Genetics created the combination COVID-19 and flu test because the symptoms between the two are so similar, but the treatme
-
Baylor Genetics Partners With Rainbow Genomics Offering Adult Wellness Screening And High-Risk Cancer Exome Sequencing Tests In Asian Pacific
9/26/2017
-
Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics For Use With The Juno System
8/18/2017
-
Baylor Genetics Selects Edico Genome's DRAGEN To Improve Turnaround Times For Clinical Tests, Enabling Physicians And Genetic Counselors To Be 'Ready With Answers' Faster Than Ever
9/20/2016